Skip to main content
AAN.com

Abstract

Purpose of Review

Sleep disorders among refugees are common yet understudied. Interventions are difficult in resource-limited settings where most of these populations live. A systematic review of sleep disorders in refugee populations is warranted to identify prevalence, comorbidities, and the limitations of the current state of sleep health among refugees.

Recent Findings

Sleep disturbances, particularly insomnia and nightmares, occur with a higher prevalence among refugees. Diseases associated with insomnia in this population included fibromyalgia, posttraumatic stress disorder, depression, and anxiety. Risk factors include trauma, migration, lower socioeconomic status, lower educational level, and settlement in areas with a high influx of new residents or proximity to conflict. Only a few partially successful therapies were identified.

Summary

This review identifies the high prevalence of the disturbed sleep in this population and its risk factors. It proposes ways of increasing awareness of it in this vulnerable population as a first step toward remediation.

Get full access to this article

View all available purchase options and get full access to this article.

References

1.
United Nations Department of Economic and Social Affairs PD. New York, NY. International Migration 2020 Highlights; 2020.
2.
Daynes L. The health impacts of the refugee crisis: a medical charity perspective. Clin Med (Lond). 2016;16(5):437-440.
3.
Kavukcu N, Altintas KH. The challenges of the health care providers in refugee settings: a systematic review. Prehosp Disaster Med. 2019;34(02):188-196.
4.
Kroening ALH, Dawson-Hahn E. Health considerations for immigrant and refugee children. Adv Pediatr. 2019;66:87-110.
5.
Al-Rousan T, AlHeresh R, Saadi A, et al. Epidemiology of cardiovascular disease and its risk factors among refugees and asylum seekers: systematic review and meta-analysis. Int J Cardiol Cardiovasc Risk Prev. 2022;12:200126.
6.
Saadi A, Al-Rousan T, AlHeresh R. Refugee mental health-an urgent call for research and action. JAMA Netw Open. 2021;4(3):e212543.
7.
Jackson CL, Redline S, Emmons KM. Sleep as a potential fundamental contributor to disparities in cardiovascular health. Annu Rev Public Health. 2015;36(1):417-440.
8.
Carnethon MR, Johnson DA. Sleep and resistant hypertension. Curr Hypertens Rep. 2019;21(5):34.
9.
Richter K, Baumgartner L, Niklewski G, et al. Sleep disorders in migrants and refugees: a systematic review with implications for personalized medical approach. EPMA J. 2020;11(2):251-260.
10.
Durmer JS, Dinges DF. Neurocognitive consequences of sleep deprivation. Semin Neurol. 2005;25(1):117-129.
11.
Al-Smadi AM, Tawalbeh LI, Gammoh OS, Ashour A, Tayfur M, Attarian H. The prevalence and the predictors of insomnia among refugees. J Health Psychol. 2019;24(8):1125-1133.
12.
Basishvili T, Eliozishvili M, Maisuradze L, et al. Insomnia in a displaced population is related to war-associated remembered stress. Stress Health. 2012;28(3):186-192.
13.
Bruck D, Atem Deng S, Kot B, Grossman M. Sleep difficulties among South Sudanese former refugees settled in Australia. Transcult Psychiatry. 2021;58(2):172-186.
14.
Lies J, Mellor A, Jobson L, Drummond SPA. Prevalence of sleep disturbance and its relationships with mental health and psychosocial issues in refugees and asylum seekers attending psychological services in Australia. Sleep Health. 2019;5(4):335-343.
15.
Lies J, Drummond SPA, Jobson L. Longitudinal investigation of the relationships between trauma exposure, post-migration stress, sleep disturbance, and mental health in Syrian refugees. Eur J Psychotraumatol. 2020;11(1):1825166.
16.
Lies J, Jobson L, Mascaro L, Whyman T, Drummond SPA. Postmigration stress and sleep disturbances mediate the relationship between trauma exposure and posttraumatic stress symptoms among Syrian and Iraqi refugees. J Clin Sleep Med. 2021;17(3):479-489.
17.
Montgomery E, Foldspang A. Traumatic experience and sleep disturbance in refugee children from the Middle East. Eur J Public Health. 2001;11(1):18-22.
18.
Aernout E, Benradia I, Hazo JB, et al. International study of the prevalence and factors associated with insomnia in the general population. Sleep Med. 2021;82:186-192.
19.
Al-Smadi AM, Tawalbeh LI, Gammoh OS, Ashour AF, Shajrawi A, Attarian H. Relationship between anxiety, post-traumatic stress, insomnia and fibromyalgia among female refugees in Jordan: a cross-sectional study. J Psychiatr Ment Health Nurs. 2021;28(4):738-747.
20.
Bronstein I, Montgomery P. Sleeping patterns of Afghan unaccompanied asylum-seeking adolescents: a large observational study. PLoS One. 2013;8(2):e56156.
21.
Gammoh OS, Al-Smadi A, Tayfur M, et al. Syrian female war refugees: preliminary fibromyalgia and insomnia screening and treatment trends. Int J Psychiatry Clin Pract. 2020;24(4):387-391.
22.
Gerhart JI, Hall BJ, Russ EU, Canetti D, Hobfoll SE. Sleep disturbances predict later trauma-related distress: cross-panel investigation amidst violent turmoil. Health Psychol. 2014;33(4):365-372.
23.
Lee J, Jeon S, Kim S, et al. Polysomnographic sleep and attentional deficits in traumatized North Korean refugees. Nat Sci Sleep. 2021;13:635-645.
24.
Muller LRF, Gossmann K, Schmid RF, Rosner R, Unterhitzenberger J. A pilot study on ecological momentary assessment in asylum-seeking children and adolescents resettled to Germany: investigating compliance, post-migration factors, and the relation between daily mood, sleep patterns, and mental health. PLoS One. 2021;16(2):e0246069.
25.
Park J, Elbert T, Kim SJ, Park J. The contribution of posttraumatic stress disorder and depression to insomnia in North Korean refugee youth. Front Psychiatry. 2019;10:211.
26.
Sakhelashvili I, Eliozishvili M, Lortkipanidze N, Oniani N, Cervena K, Darchia N. Sleep quality among internally displaced Georgian adolescents and population-based controls. J Child Health Care. 2016;20(3):384-393.
27.
Sakhelashvili I, Eliozishvili M, Oniani N, Darchia N, Bruni O. Sleep and psycho-behavioral problems in internally displaced children in Georgia. Sleep Med. 2018;50:42-47.
28.
Sandahl H, Jennum P, Baandrup L, Lykke Mortensen E, Carlsson J. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: results from a randomized controlled trial. J Sleep Res. 2021;30(4):e13276.
29.
Belleville G, Guay S, Marchand A. Persistence of sleep disturbances following cognitive-behavior therapy for posttraumatic stress disorder. J Psychosomatic Res. 2011;70(4):318-327.
30.
Zhao K, Zhang J, Wu Z, Shen X, Tong S, Li S. The relationship between insomnia symptoms and school performance among 4966 adolescents in Shanghai, China. Sleep Health. 2019;5(3):273-279.
31.
Gammoh OS, Al-Smadi A, Mukattash T, Al-Katib W, Attarian H, Al-Shawagfeh M. Efficacy of single dose antihistamine vs. single dose valerian-hops in subjective sleep measures among war refugees: a comparison trial. Arch Clin Psychiatry (São Paulo). 2017;44(2):35-39.
32.
Jespersen KV, Vuust P. The effect of relaxation music listening on sleep quality in traumatized refugees: a pilot study. J Music Ther. 2012;49(2):205-229.
33.
Park JK, Park J, Elbert T, Kim SJ. Effects of narrative exposure therapy on posttraumatic stress disorder, depression, and insomnia in traumatized North Korean refugee youth. J Traumatic Stress. 2020;33(3):353-359.
34.
Zehetmair C, Nagy E, Leetz C, et al. Self-practice of stabilizing and guided imagery techniques for traumatized refugees via digital audio files: qualitative study. J Med Internet Res. 2020;22(9):e17906.
35.
Jespersen KV, Otto M, Kringelbach M, Van Someren E, Vuust P. A randomized controlled trial of bedtime music for insomnia disorder. J Sleep Res. 2019;28(4):e12817.
36.
Itani O, Kaneita Y, Munezawa T, et al. Nationwide epidemiological study of insomnia in Japan. Sleep Med. 2016;25:130-138.
37.
Cao XL, Wang SB, Zhong BL, et al. The prevalence of insomnia in the general population in China: a meta-analysis. PLoS One. 2017;12(2):e0170772.
38.
Pengo MF, Won CH, Bourjeily G. Sleep in women across the life span. Chest. 2018;154(1):196-206.
39.
Dolsen EA, Crosswell AD, Prather AA. Links between stress, sleep, and inflammation: are there sex differences? Curr Psychiatry Rep. 2019;21(2):8.
40.
Germain A. Sleep disturbances as the hallmark of PTSD: where are we now? Am J Psychiatry. 2013;170(4):372-382.
41.
Steel Z, Chey T, Silove D, Marnane C, Bryant RA, van Ommeren M. Association of torture and other potentially traumatic events with mental health outcomes among populations exposed to mass conflict and displacement: a systematic review and meta-analysis. JAMA. 2009;302(5):537-549.
42.
Nyer M, Farabaugh A, Fehling K, et al. Relationship between sleep disturbance and depression, anxiety, and functioning in college students. Depress Anxiety. 2013;30(9):873-880.
43.
Baglioni C, Battagliese G, Feige B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affective Disord. 2011;135(1-3):10-19.
44.
McGovney KD, Curtis AF, McCrae CS. Associations between objective afternoon and evening physical activity and objective sleep in patients with fibromyalgia and insomnia. J Sleep Res. 2021;30(1):e13220.
45.
Huang CJ, Huang CL, Fan YC, Chen TY, Tsai PS. Insomnia increases symptom severity and health care utilization in patients with fibromyalgia: a population-based study. Clin J Pain. 2019;35(9):780-785.
46.
Hedin G, Norell-Clarke A, Hagell P, Tonnesen H, Westergren A, Garmy P. Insomnia in relation to academic performance, self-reported health, physical activity, and substance use among adolescents. Int J Environ Res Public Health. 2020;17(17):6433.
47.
Gruber R, Sadeh A, Raviv A. Instability of sleep patterns in children with attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2000;39(4):495-501.
48.
Everitt H, Baldwin DS, Stuart B, et al. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018;5:CD010753.
49.
Salter S, Brownie S. Treating primary insomnia - the efficacy of valerian and hops. Aust Fam Physician. 2010;39(6):433-437.
50.
Saitou K, Kaneko Y, Sugimoto Y, Chen Z, Kamei C. Slow wave sleep-inducing effects of first generation H1-antagonists. Biol Pharm Bull. 1999;22(10):1079-1082.
51.
Berlin KL, Means MK, Edinger JD. Nightmare reduction in a Vietnam veteran using imagery rehearsal therapy. J Clin Sleep Med. 2010;06(05):487-488.
52.
Edinger JD, Arnedt JT, Bertisch SM, et al. Behavioral and psychological treatments for chronic insomnia disorder in adults: an American Academy of Sleep Medicine clinical practice guideline. J Clin Sleep Med. 2021;17(2):255-262.
53.
Sateia MJ, Buysse DJ, Krystal AD, Neubauer DN, Heald JL. Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American academy of sleep medicine clinical practice guideline. J Clin Sleep Med. 2017;13(02):307-349.
54.
Arnedt JT, Conroy DA, Mooney A, Furgal A, Sen A, Eisenberg D. Telemedicine versus face-to-face delivery of cognitive behavioral therapy for insomnia: a randomized controlled noninferiority trial. Sleep. 2021;44(1):zsaa136.
55.
Eluka NN, Morrison SD, Sienkiewicz HS. "The Wheel of My Work": community health worker perspectives and experiences with facilitating refugee access to primary care services. Health Equity. 2021;5(1):253-260.
56.
Peeler KR, Hampton K, Lucero J, Ijadi-Maghsoodi R. Sleep deprivation of detained children: another reason to End child detention. Health Hum Rights. 2020;22(1):317-320.
57.
Hoffman SJ, Stich J, Musani S, Robertson CL. Sleeping in a boundary" constructing the meaning of health in a refugee camp. Health Care Women Int. 2019;40(7-9):744-760.

Information & Authors

Information

Published In

Neurology® Clinical Practice
Volume 13Number 2April 2023

Publication History

Received: September 16, 2022
Accepted: December 5, 2022
Published online: March 14, 2023
Published in print: April 2023

Permissions

Request permissions for this article.

Disclosure

The authors have no disclosures relevant to this manuscript. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.

Study Funding

The authors report no targeted funding.

Authors

Affiliations & Disclosures

Department of Neurology (AB), University of Chicago, IL; Department of Internal Medicine (EM), University of California San Francisco, CA; American University of Beirut (RB), Lebanon; Department of Neurology (HA), Northwestern University, Chicago, IL; Department of Neurology (AS), MGH Asylum Clinic, Harvard Medical School, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Department of Neurology (AB), University of Chicago, IL; Department of Internal Medicine (EM), University of California San Francisco, CA; American University of Beirut (RB), Lebanon; Department of Neurology (HA), Northwestern University, Chicago, IL; Department of Neurology (AS), MGH Asylum Clinic, Harvard Medical School, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Ricardo Bitar, BS
Department of Neurology (AB), University of Chicago, IL; Department of Internal Medicine (EM), University of California San Francisco, CA; American University of Beirut (RB), Lebanon; Department of Neurology (HA), Northwestern University, Chicago, IL; Department of Neurology (AS), MGH Asylum Clinic, Harvard Medical School, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
None
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE
Department of Neurology (AB), University of Chicago, IL; Department of Internal Medicine (EM), University of California San Francisco, CA; American University of Beirut (RB), Lebanon; Department of Neurology (HA), Northwestern University, Chicago, IL; Department of Neurology (AS), MGH Asylum Clinic, Harvard Medical School, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
Associate Editor for Gender and the Genome and for Current Reports in Sleep Medicine
Patents:
1.
NONE
Publishing Royalties:
1.
Sleep Disorders In Women, Springer 2019, royalties received 2020
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
Consultant for Harmony Bioscience, GLG and Clearview all are commercial entities
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
NONE
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
Michael J Fox Foundation. Site co-PI for PPMI
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
Expert witness for defendant.
Department of Neurology (AB), University of Chicago, IL; Department of Internal Medicine (EM), University of California San Francisco, CA; American University of Beirut (RB), Lebanon; Department of Neurology (HA), Northwestern University, Chicago, IL; Department of Neurology (AS), MGH Asylum Clinic, Harvard Medical School, Boston, MA.
Disclosure
Scientific Advisory Boards:
1.
None
Gifts:
1.
NONE
Funding for Travel or Speaker Honoraria:
1.
None
Editorial Boards:
1.
NONE
Patents:
1.
NONE
Publishing Royalties:
1.
NONE
Employment, Commercial Entity:
1.
NONE
Consultancies:
1.
NONE
Speakers' Bureaus:
1.
NONE
Other Activities:
1.
NONE
Clinical Procedures or Imaging Studies:
1.
NONE
Research Support, Commercial Entities:
1.
NONE
Research Support, Government Entities:
1.
1) National Science Foundation, Grant number 2116859, Co-PI, 2021-20242) National Institute of Health, R21MD017499, MPI, 2022-2024
Research Support, Academic Entities:
1.
NONE
Research Support, Foundations and Societies:
1.
1) Russel Sage Foundation, 2021-20232) American Academy of Neurology, 2021-20233) Rappaport Foundation, 2020-2021
Stock/stock Options/board of Directors Compensation:
1.
NONE
License Fee Payments, Technology or Inventions:
1.
NONE
Royalty Payments, Technology or Inventions:
1.
NONE
Stock/stock Options, Research Sponsor:
1.
NONE
Stock/stock Options, Medical Equipment & Materials:
1.
NONE
Legal Proceedings:
1.
NONE

Notes

Correspondence Dr. Attarian [email protected]
Funding information and disclosures are provided at the end of the article. Full disclosure form information provided by the authors is available with the full text of this article at Neurology.org/cp.
Submitted and externally peer reviewed. The handling editor was Associate Editor John P. Ney, MD, MPH.
*
These authors contributed equally as senior authors.

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By

View Options

Get Access

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

Purchase this article to get full access to it.

Purchase Access, $39 for 24hr of access

View options

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share